The New Age of Digital Health
Wednesday, January 27th, 2021 @ 5:30pm PST (1.5 hours)
The MIT Enterprise Forum of San Diego is excited to host this relevant and timely discussion. Please join us on January 27th at 5:30pm PST.
Meeting info provided upon registration.
Discussion to focus around the increasing importance of digital therapeutics in clinical care, the role of the patient, patient monitoring and the impact on reducing the costs of healthcare. A focus on Diabetes makes a useful use-case, as an example of the earliest and most advanced self-managed conditions.
Possible questions to consider:
- Take the audience on a journey of the past, (self-managed) current, (digital engagement) and future, (AI?) of diabetes patient management
- What changes in the healthcare landscape have made digital therapeutics more valuable/accessible?
- What kinds of impacts, on patient care as well as on health systems, can be identified by increased availability and deployment of digital therapeutic tools?
- Other than Diabetes, what other chronic conditions are benefitting by increased use of digital therapeutics? Why is this important?
- What do we anticipate seeing in the next 5-10 years?
Elizabeth Gasser, Executive Vice President, Strategy and Corporate Development, Tandem Diabetes
Elizabeth Gasser joined Tandem Diabetes Care as Executive Vice President Strategy and Corporate Development in January 2020. She previously worked as an independent advisor providing strategic and corporate development solutions to boards and executive teams. Prior to this, Ms. Gasser was VP of Corporate Strategy at Qualcomm Technologies, Inc. where she worked from July 2006 to June 2017. Ms. Gasser has over 20 years of strategy and transaction experience, with an emphasis on developing and leading market entry and growth strategies for connected ecosystems and data-driven businesses. Ms. Gasser holds a B.A. and M.A. in Economics from the University of Cambridge.
Arnold Saperstein MD, FACP, began his career in managed care in 1992 and joined MetroPlus Health Plan in 1995 initially as Chief Medical Officer and then as President and CEO from 2006 until 2019. MetroPlus Health Plan, a wholly-owned subsidiary of the New York City Health + Hospitals is a managed care organization that, under Saperstein’s leadership grew from 40,000 members to over 500,000 members with an estimated 32,000 participating providers.
Dr. Saperstein has spent the majority of his career developing programs that ensure the highest quality of care. During his tenure at MetroPlus, it ranked as one of the highest scoring plans for quality of care as measured by the New York State Department of Health Medicaid Incentive Program and by the Medicaid Consumer Guide for New York City. Under his leadership, MetroPlus rose to the forefront of Value Based Purchasing. Programs he developed included groundbreaking quality incentive pay for performance programs across the entire MetroPlus network.
Dr. Saperstein is a graduate of New York University School of Medicine and completed his residency in Internal Medicine and fellowship in Endocrinology at the New York University programs.
Dr. Saperstein joined Cecelia Health in July 2019 as the Chief Medical Officer. Cecelia Health is an innovative Diabetes care management organization combining the latest technology with personalized human touch.
At Cecelia Health, Dr. Saperstein built a fully virtual Diabetes practice functional in all 50 states. The practice includes Endocrinologists licensed in every state as well as a team of expert Certified Diabetes Care and Education Specialists
Dr. Saperstein also oversees all of the clinical care delivered by the Cecelia Health staff and ensures the highest quality of care and outcomes
Linda Travis Macomber, RN BSN MBA, is Program Director and faculty at National University based in La Jolla, CA. Professor Macomber founded the MS Health Informatics program in 2010 and currently leads faculty, develops curriculum, runs the Virtual Health Tech Discovery Lab, facilities partnerships, and teaches/advises students in emerging health IT practices. Since first launching her health IT career in 1984, she has led pioneering and comprehensive digital health and tech-enabled initiatives with hospitals, clinics, consulting firms, biotech, tech developers, and startups. Professor Macomber earned her BSN from the University of Michigan and her MBA from Northeastern University. She has published and presented extensively on health tech innovations as her life and career have taken her to all 50 states and five continents. Presentation highlights included invitations to speak in South Africa, Finland, and at many national HIMSS meetings.
Career highlights include launching many health tech initiatives decades before they became mainstream.
- In the 1980s, she pioneered the development and deployment of Mumps-based health applications in Boston area hospitals and beyond. She joined the team to develop/launch the 1987 pilot and win the 1.01 billion-dollar DOD Composite Health Care System (CHCS) award. This solution included eprescribing, CPOE, decision support, and person-centered system integration creating a global legacy that has lasted the test of time.
- In the 1990s, she led a requirements design team for Kaiser Permanente’s HealthConnect predecessor, contributed to what is now Cancer.gov, and launched the firm Healthcare Technology Consulting. Clients have included IBM, SAIC (Leidos), Healthlink, Genentech, Anvita Health (Humana), the University of California, the National Cancer Institute (NCI), and startups.
- In the 2000s, she founded and chaired a national HIMSS Davies Award, led community clinic EHR grants/initiatives, and designed tech-enabled patient care for clinics, including the White House and Executive Health Clinic at Walter Reed.
- She began her career with the University of Michigan Alumni Association and then as a pediatric RN and ICU nurse at the Harvard Medical School-affiliated Boston Children’s Hospital. She joined HIMSS in 1989 as part of founding clinical systems participation and ANIA in1993 as the organization was starting up.
- Professor Macomber lives in San Diego and has one daughter who is currently a Ph.D. candidate in Neuroscience at the University of Chicago. Current interests include virtual care/ telehealth, personal health technologies, ed-tech innovations, decision support, writing, innovative health technology adoption, and developing the next generation of health tech leaders.
Visit Our Website to stay updated on future programs.
We look forward to connecting with you,
The Chapter Executive Committee & Advisory Board
MIT Enterprise Forum-San Diego Chapter